Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Page 4 of 100

  • Biden July 4 COVID vaccine goalHealth

    The U.S. won’t make the President’s July 4 vaccination target. Here’s what that means

    By
  • Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty ImagesHealth

    Pressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows

    By
  • Juneteenth Black diversity officers health inequalityLeadership

    3 Black diversity chiefs on how they’ll fight racial inequality in medicine

    By
  • Juneteenth Black diversity officers health inequalityNewsletters

    Three Black health care diversity officers. One united goal

    By
  • A demonstrator holds a sign in front of the US Supreme Court in Washington, DC, on November 10, 2020, as the high court opened arguments in the long-brewing case over the constitutionality of the 2010 Affordable Care Act, under which then-president Barack Obama’s government sought to extend health insurance to people who could not afford it. – President Donald Trump’s outgoing administration took aim in the US Supreme Court Tuesday at razing the “Obamacare” health program his predecessor built, a move which could cancel the health insurance of millions in the middle of the Covid-19 pandemic. (Photo by NICHOLAS KAMM / AFP) (Photo by NICHOLAS KAMM/AFP via Getty Images)Health

    The decade-long battle against Obamacare reaches a likely end with new Supreme Court decision

    By
  • COVID delta variantHealth

    What you should know about the Delta variant and what it means for reopening

    By
  • COVID vaccines heart inflammationHealth

    What we know about COVID vaccines, heart inflammation, and its implications for drug makers

    By
  • Biogen aducanumab FDA approvalNewsletters

    What comes next after the Biogen Alzheimer’s drug approval

    By
  • The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.Health

    Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?

    By
  • The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.Health

    FDA approves Biogen’s controversial Alzheimer’s drug in historic decision

    By
  • New Fortune 500 CEOS 2021Newsletters

    The health care companies leading 2021’s Fortune 500 list

    By
  • President Joe Biden delivers remarks about the Colonial Pipeline hack, in the Roosevelt Room of the White House, Thursday, May 13, 2021, in Washington. (AP Photo/Evan Vucci)Newsletters

    Abortion, Obamacare, and drug approvals: American health care faces a pivotal moment

    By
  • FDA Biogen Alzheimer's Janet WoodcockHealth

    President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals

    By
  • COVID vaccines militaryHealth

    The U.S. military had a COVID vaccine skepticism problem. But now it’s seeing a massive jump in shots

    By
  • Pharmaceutical Executives Testify At Senate Finance Committee Hearing On Drug PricesNewsletters

    Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?

    By